Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05769283 · ClinicalTrials.gov registry record · NA
Vaginal Injection of Platelet Rich Plasma for Sexual Function
A NA study, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT05769283: Completed NA study, sponsored by Medstar Health Research Institute.
NCT05769283 is a NA study that has completed, run by Medstar Health Research Institute. The registered enrollment target is 52 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05769283, a NA study, has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn about an injection of platelet rich plasma into the vaginal wall and around the clitoris. The main questions it aims to answer are: * To see if a PRP injection improves sexual satisfaction * To learn the effect of PRP injections on sexual function Participants will get assigned to getting a one time PRP injection or a placebo injection. They will answer questionnaires about their sexual function at their first visit and their followup visit. The investigators will then compare the two groups.
Primary Outcome
To determine if PRP injections into the anterior vaginal wall and peri-clitoral region alter sexual function or satisfaction in sexually active women without a prior history of FSD. This will be determine using the Female Sexual Function Index (FSFI) pre and post procedure. The FSFI is a validated questionnaire with 6 domains of desire, subjective arousal, lubrication, orgasm, satisfaction, and pain with a scale of 0-36. A higher score on this questionnaire correlates with higher sexual satisfac
Interventions
- OTHER Saline
- OTHER Platelet Rich Plasma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2023-08-18 |
| Est. Completion | 2025-03-21 |
| Phase | NA |
What the finished NCT05769283 record still lists
NCT05769283 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT05769283 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05769283 about?
NCT05769283 is a clinical study titled "Vaginal Injection of Platelet Rich Plasma for Sexual Function". The goal of this clinical trial is to learn about an injection of platelet rich plasma into the vaginal wall and around the clitoris. The main questions it aims to answer are: * To see if a PRP injection improves sexual satisfaction * To learn the effect of PRP injections on sexual function Partici...
What is the current status of trial NCT05769283?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2023-08-18. Estimated completion is 2025-03-21.
What interventions are being tested in trial NCT05769283?
The interventions under investigation include: Saline (OTHER), Platelet Rich Plasma (OTHER).
Who is sponsoring clinical trial NCT05769283?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05769283's enrollment target sits among peer trials
52 1272nd of 2000 higher than 722 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI